Technical Analysis for NTRA - Natera, Inc.

Grade Last Price % Change Price Change
C 102.15 -6.03% -6.55
NTRA closed down 6.03 percent on Thursday, March 4, 2021, on 1.97 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical NTRA trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Fell Below 20 DMA Bearish -6.03%
Fell Below 50 DMA Bearish -6.03%
Multiple of Ten Bearish Other -6.03%
Lower Bollinger Band Touch Weakness -6.03%
Multiple of Ten Bearish Other -13.45%
Upper Bollinger Band Touch Strength -13.45%
Older End-of-Day Signals for NTRA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 7 hours ago
60 Minute Opening Range Breakdown about 7 hours ago
Down 5% about 10 hours ago
Down 3% about 10 hours ago
Down 2 % about 10 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Natera, Inc. Description

Natera, Inc., a genetic testing company, develops and commercializes non-invasive methods for analyzing deoxyribonucleic acid (DNA) in the United States and Europe. The company primarily offers Panorama, a non-invasive prenatal test for fetal chromosomal abnormalities; Horizon test; and pre-implantation genetic screening and pre-implantation genetic diagnosis tests under the Spectrum brand to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization. It also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal DNA in a pregnant mother's blood and a blood sample from the alleged father; and high throughput carrier screening to determine the risk of passing severe genetic diseases on to offspring. Natera sells its tests directly and partner with other clinical laboratories to distribute its tests. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Acid Lab Testing In Vitro Medical Genetics Medical Tests Genetic Disease Genetic Diseases Applied Genetics DNA Genetic Testing In Vitro Fertilization DNA Paternity Testing Severe Genetic Diseases

Is NTRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 127.19
52 Week Low 16.87
Average Volume 828,469
200-Day Moving Average 75.49
50-Day Moving Average 112.47
20-Day Moving Average 115.70
10-Day Moving Average 113.18
Average True Range 7.77
ADX 15.12
+DI 21.03
-DI 31.98
Chandelier Exit (Long, 3 ATRs ) 102.41
Chandelier Exit (Short, 3 ATRs ) 124.47
Upper Bollinger Band 126.20
Lower Bollinger Band 105.20
Percent B (%b) -0.15
BandWidth 18.16
MACD Line -0.45
MACD Signal Line 0.96
MACD Histogram -1.4092
Fundamentals Value
Market Cap 8.72 Billion
Num Shares 85.4 Million
EPS -2.02
Price-to-Earnings (P/E) Ratio -50.64
Price-to-Sales 18.40
Price-to-Book 13.47
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 114.83
Resistance 3 (R3) 115.90 112.75 112.71
Resistance 2 (R2) 112.75 109.52 112.21 112.01
Resistance 1 (R1) 107.45 107.53 105.88 106.38 111.30
Pivot Point 104.30 104.30 103.51 103.76 104.30
Support 1 (S1) 99.00 101.07 97.43 97.93 93.00
Support 2 (S2) 95.85 99.08 95.31 92.29
Support 3 (S3) 90.55 95.85 91.59
Support 4 (S4) 89.48